MBX Biosciences, Inc.

MBX Biosciences is a clinical-stage biopharmaceutical company focused on developing novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company was founded by industry leaders with expertise in peptide drug design and development, leading to the creation of their proprietary Precision Endocrine Peptide™ (PEP™) platform. PEPs are engineered to overcome the limitations of native peptides, such as short half-lives, by optimizing their pharmaceutical properties for extended duration of action, consistent drug concentrations, and less frequent dosing.

MBX Biosciences is advancing a pipeline of PEP candidates for a range of endocrine and metabolic disorders, including hypoparathyroidism, post-bariatric hypoglycemia, and obesity. Their lead product candidate, MBX 2109, is currently in Phase 2 development for the treatment of chronic hypoparathyroidism. MBX is committed to developing innovative therapies that improve the lives of patients suffering from these disorders and is supported by leading life science investors.

MBX Biosciences offers a hybrid work environment, allowing employees to balance their personal and professional lives. They offer flexible PTO and 12 paid holidays, and provide a monthly stipend for cell phone and home internet. The company also encourages team events and collaborative work culture, creating a positive workplace experience for its employees.

MBX Biosciences offers a comprehensive benefits package designed to attract and retain top talent while promoting work-life balance. Their offerings include competitive base pay and annual bonus opportunities, a hybrid and remote work environment, flexible paid time off and 12 paid holidays, a monthly stipend for cell phone and home internet, and a variety of health and well-being benefits like medical, dental, and vision plans, flexible spending accounts, short- and long-term disability, and mental health services. They also provide investment opportunities in the company through an equity program and 401(k) savings plan, as well as life insurance and professional development planning.

MBX Biosciences is a clinical-stage biopharmaceutical company committed to improving the lives of individuals with endocrine and metabolic disorders. They are pioneering Precision Endocrine Peptides™ (PEPs™) as a new generation of peptide therapeutics, designed to overcome the limitations of traditional peptide treatments and offer more efficacious, safe, and convenient options for patients. Their mission is to help people with these conditions live fuller and healthier lives by developing innovative medicines that address unmet needs in underserved markets.

MBX Biosciences fosters a collaborative and inclusive work environment built on the foundation of transparency, integrity, and innovation. The company values teamwork, actively encourages a marketplace of ideas, and believes in the importance of representing the diversity of the communities it serves. They prioritize a positive workplace culture and employee experience, offering hybrid and remote work opportunities, comprehensive compensation packages, and a focus on employee growth and well-being.

MBX Biosciences is committed to fostering a diverse, equitable, and inclusive workplace. They believe in creating an environment where all employees feel valued, respected, and empowered to contribute their unique perspectives. They strive to build a team that reflects the communities they serve, offer flexible work arrangements, and prioritize professional development opportunities to ensure inclusivity and support the growth of all employees.